We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Siemens to Sell Life Support Systems to Getinge

By HospiMedica staff writers
Posted on 10 Sep 2003
Print article
To comply with requirements of the European Union (EU) anti-trust authority regarding a joint venture in the field of critical care, Siemens Medical Solutions (Erlangen, Germany) will sell its Life Support Systems division to Getinge AG (Stockholm, Sweden) for 200 million euros.

The products of Life Support Systems are used for maintaining vital patient functions. These products include anesthesia and respiratory systems used in the operating room and intensive care units. The division had sales of more than 200 million euros in 2002. Getinge will integrate Life Support Systems into its Surgical Systems division. Siemens announced the decision to divest its Life Support Systems in March 2003 to meet regulatory requirements established by the EU for the company's joint venture with Draegerwerk AG (Luebeck, Germany) in critical care.

"Our selection of investors focused primarily on a successful development of the business and a reliable partner for our customers,” said Dr. Erich R. Reinhardt, president and CEO of Siemens Medical Solutions.





Related Links:
Siemens
Getinge
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Dry Thawing & Warming System
SAHARA-TSC 230 V
New
Surgeon Stool with Armrests & Backrest
MR4502

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.